Erin Hahn to Breast Neoplasms
This is a "connection" page, showing publications Erin Hahn has written about Breast Neoplasms.
Connection Strength
2.591
-
Barriers and facilitators to implementation and sustainment of guideline-recommended depression screening for patients with breast cancer in medical oncology: a qualitative study. Support Care Cancer. 2023 Jul 12; 31(8):461.
Score: 0.500
-
Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial. JAMA. 2022 01 04; 327(1):41-49.
Score: 0.450
-
Anxiety, Culture, and Expectations: Oncologist-Perceived Factors Associated With Use of Nonrecommended Serum Tumor Marker Tests for Surveillance of Early-Stage Breast Cancer. J Oncol Pract. 2017 01; 13(1):e77-e90.
Score: 0.315
-
Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer. 2016 Mar 15; 122(6):908-16.
Score: 0.296
-
Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract. 2015 May; 11(3):e320-8.
Score: 0.283
-
Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer. 2013 Dec 15; 119(24):4316-24.
Score: 0.253
-
Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv. 2013 Sep; 7(3):323-30.
Score: 0.245
-
Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008 Feb 10; 26(5):759-67.
Score: 0.172
-
Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena). Clin Breast Cancer. 2016 10; 16(5):356-363.
Score: 0.076